328 related articles for article (PubMed ID: 12478252)
21. Regulators split on gene therapy as patient shows signs of cancer.
Check E
Nature; 2002 Oct; 419(6907):545-6. PubMed ID: 12374936
[No Abstract] [Full Text] [Related]
22. NIH tightens up monitoring of gene-therapy mishaps.
Smaglik P
Nature; 2000 Mar; 404(6773):5. PubMed ID: 10716412
[No Abstract] [Full Text] [Related]
23. Panel advises resuming genetic studies: U.S. agency halted trials after boy fell ill in French experiment.
Stolberg SG
N Y Times Web; 2002 Oct; ():A30. PubMed ID: 12474841
[No Abstract] [Full Text] [Related]
24. IRBs and monitoring the safety of clinical trials.
Maloney DM
Hum Res Rep; 2003 Jan; 18(1):3. PubMed ID: 12755095
[No Abstract] [Full Text] [Related]
25. Tighter watch urged on adenoviral vectors...with proposal to report all 'adverse events'.
Smaglik P
Nature; 1999 Dec; 402(6763):707. PubMed ID: 10617181
[No Abstract] [Full Text] [Related]
26. Gene therapy: shining hopes dented - but not dashed.
Check E
Nature; 2002 Dec 19-26; 420(6917):735. PubMed ID: 12490910
[No Abstract] [Full Text] [Related]
27. New rules for gene-transfer trials.
Nelson RM
IRB; 2001; 23(6):11. PubMed ID: 12737176
[No Abstract] [Full Text] [Related]
28. FDA panel recommends easing gene therapy trial limits.
Fox JL
Nat Biotechnol; 2003 Apr; 21(4):344-5. PubMed ID: 12665806
[No Abstract] [Full Text] [Related]
29. NIH panel may increase gene-trial scrutiny..
Smaglik P
Nature; 2000 Jun; 405(6788):724. PubMed ID: 10866166
[No Abstract] [Full Text] [Related]
30. Light, fast, and flexible: a new approach to regulation of human gene therapy.
Cregan JA
McGeorge Law Rev; 2000; 32(1):261-87. PubMed ID: 15709266
[No Abstract] [Full Text] [Related]
31. French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy.
European Society of Gene Therapy
J Gene Med; 2003 Jan; 5(1):82-4. PubMed ID: 12516054
[No Abstract] [Full Text] [Related]
32. Second cancer case halts gene-therapy trials.
Check E
Nature; 2003 Jan; 421(6921):305. PubMed ID: 12540867
[No Abstract] [Full Text] [Related]
33. NIH under fire over gene-therapy trials..
Wadman M
Nature; 2000 Jan; 403(6767):237. PubMed ID: 10659820
[No Abstract] [Full Text] [Related]
34. Temporary halt on gene therapy trials.
FDA Consum; 2003; 37(2):6. PubMed ID: 12715756
[No Abstract] [Full Text] [Related]
35. SCID trials to remain on the 'bubble'.
Mandavilli A
Nat Med; 2003 Mar; 9(3):251. PubMed ID: 12612562
[No Abstract] [Full Text] [Related]
36. Trials are halted on gene therapy: child in experiment falls ill--new setback for research.
Stolberg SG
N Y Times Web; 2002 Oct; ():A1, A25. PubMed ID: 12474837
[No Abstract] [Full Text] [Related]
37. FDA halts 27 gene therapy trials after illness: leukemia-like cases in 2 children in France prompt the action.
Pollack A
N Y Times Web; 2003 Jan; ():A1, A17. PubMed ID: 12647754
[No Abstract] [Full Text] [Related]
38. Gene therapy. What to do when clear success comes with an unclear risk?
Marshall E
Science; 2002 Oct; 298(5593):510-1. PubMed ID: 12386304
[No Abstract] [Full Text] [Related]
39. Institutional review boards must conduct safety review.
Maloney DM
Hum Res Rep; 2005 Feb; 20(2):3. PubMed ID: 15839005
[No Abstract] [Full Text] [Related]
40. Bubble babies and bathwater.
Nat Biotechnol; 2002 Nov; 20(11):1063. PubMed ID: 12410236
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
